EMD-101

N/A

Report date: 2025/08/20 16:52:42

Base Information

Drug NameEMD-101

Drug Alias NameEMD-101

ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas9Cell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy

Mechanisms of ActionLeukocyte elastase inhibitors

TargetsLeukocyte elastase

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEmendobio Inc

China Registration ClassN/A

Develop Information

Active CompaniesEmendobio Inc

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeN/A